❤️In ASCVD patients high‑intensity LDL lowering cuts #Lp(a) linked risk & PCSK9i add extra benefit
No significant interaction suggests #PCSK9i deliver consistent risk ⬇️regardless of baseline Lp(a)

tinyurl.com/5eb97nmb

@eassociety.bsky.social #EHJ #EAS
#BorgeNordestgaard #DianeMacDougall